For decades, dermatological textbooks categorized Cutibacterium acnes as an inherently pathogenic bacterium that required eradication. However, high-throughput genomic sequencing has overturned this dogma, revealing that C. acnes is a dominant, beneficial commensal organism whose internal phylotype balance dictates inflammatory outcomes.
Phylotype Disparities: IA1 vs. II and III
Metagenomic profiling distinguishes several distinct phylogenetic clades of C. acnes:
- Phylotype IA1: Strongly associated with inflammatory acne vulgaris. Strains within this clade express potent virulence factors, including hyaluronate lyase, Christie-Atkins-Munch-Petersen (CAMP) factors, and pro-inflammatory porphyrins.
- Phylotypes II and III: Predominantly associated with healthy, clear skin. These benign strains produce short-chain fatty acids (SCFAs) that maintain acidic cutaneous pH and inhibit colonization by Staphylococcus aureus.
The Dangers of Broad-Spectrum Sterilization
Indiscriminate use of high-strength alcohol washes and chronic topical antibiotics decimates protective commensal strains, leading to microbial dysbiosis. Modern dermatological approaches focus on restoring phylotypic diversity through prebiotics, bacteriophage therapy, and microbiome-friendly lipid emollients.